All Type of News
Korea’s new drug pricing reform faces backlash
The government’s plan to cut drug prices by an average of 17 percent starting next year has triggered vehement protests from the domestic pharmaceutical community.
An alliance of 10 pharmaceutical-related organiza...
National Assembly seeking to include Dong-A’s Chairman to include witness list
Lawmakers of the National Assembly’s Welfare Committee said Wednesday that they will look closely at the government’s bill to allow supermarkets to sell over-the counter drugs during the National Assembly inspection t...
JW Pharmaceutical Group names foreign CSO
JW Pharmaceutical Group has hired a foreign R&D expert to lead its global business operations.
The company said Wednesday it appointed Dr. Glenn Noronha, a senior scientist of Pharmaceutical Development at Novartis...
Discontent mounting over new drug pricing reform
The government’s decision to cut domestic drug prices by an average of 17 percent starting next year met with strong backlash from the pharmaceutical industry.
“The Health Ministry’s senseless policy to cut drug pr...
Dong-A to release Bacchus-F
Ending weeks of silence over whether it would provide Bacchus to retailers, Dong-A Pharmaceutical, the nation’s No. 1 pharmaceutical company, finally announced that it would revive the production of Bacchus-F - discon...
NHIC, healthcare providers to start talks over 2012 NHI price
The National Health Insurance Corp. and the local six healthcare providers, including Korean Pharmaceutical Association and Korea Medical Association, will begin talks in the middle of this month to discuss the increa...
OTC drug abuse
Over-the-counter drug abuse can often lead to psychological and physical dependence. People use increased amounts of drugs to ensure a sense of well-being while treating unrelated illnesses or health problems, or for ...
Allergan Korea names new CEO
Allergan Korea said it has named Stephene Nardo, Allergan’s ex-general manager of pharmaceutical marketing in Asia-Pacific region, to replace Patrick Holt, as of August 16.
Nardo served as director of GlaxoSmithKli...
Korean drug firms gear up for domestic competitiveness
Korean pharmaceutical companies are trying hard to improve their local competitiveness, though their efforts are due to the government’s plan to cut drug prices that are expected to fall about 17 percent on average be...
Looming revenue drop is changing the economics of pharmaceutical industry
Multinational pharmaceutical firms will face a bumpy road in Korea as the patents on their blockbusters, which were filed years before the drugs went on sale, last for 20 years at most, and many expire soon.
The Fa...
